Exidavnemab

Tax included
Exidavnemab (ABBV-0805; BAN-0805) is a human IgG4 monoclonal antibody that selectively targets soluble human α-synuclein aggregates with a KD value of 18.5 pM and a KD value of 2.2 μM for α-synuclein monomers. Exidavnemab is used in Parkinson's disease research.
MedChemExpress 
HY-P99609

Data sheet

Size
Multiple sizes
Reactivity
α-synuclein
Application
Neuroscience-Neurodegeneration
CAS
2438229-02-6